Kalind board approves fund raising up to USD 65 Million
Kalind Limited's board approved raising up to USD 65 Million through equity shares, convertible bonds, and other instruments on July 22, 2026. The funds will be raised in one or more tranches via preferential issue, private placement, or qualified institutional placement, subject to shareholder and regulatory approvals.

*this image is generated using AI for illustrative purposes only.
Kalind Limited's board has approved raising funds up to USD 65 Million through various permitted instruments. The decision was taken during a board meeting held on July 22, 2026, at the company's registered office. The capital will be raised in one or more tranches via equity shares, convertible bonds, debentures, warrants, preference shares, or foreign currency convertible bonds (FCCBs).
The fund-raising methods include preferential issue, private placement, qualified institutional placement, and share swap. The securities may be issued for cash or other considerations, including a premium, and may be listed or unlisted. The initiative is subject to necessary shareholder, regulatory, and statutory approvals.
Fund Raising Instruments
The company outlined the following instruments for capital generation:
- Equity shares
- Convertible bonds
- Debentures
- Warrants
- Preference shares
- Foreign currency convertible bonds (FCCBs)
- Any other equity-linked securities
Meeting Details
| Parameter | Details |
|---|---|
| Date | July 22, 2026 |
| Time | 01:20 P.M. to 01:40 P.M. |
| Venue | Registered office |
| Approved Amount | USD 65 Million |
Historical Stock Returns for Kalind
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.90% | -1.00% | -8.98% | +4.33% | +365.67% | +10,750.00% |
What specific strategic initiatives or acquisitions does Kalind Limited plan to finance with the raised capital?
How will the issuance of equity or convertible instruments impact the company's earnings per share and existing shareholder dilution?
Which specific instruments or tranches is the company likely to prioritize given the current market interest rate environment?


































